Hepatitis and Viral Liver Diseases
Hepatitis refers to the inflammation of the liver and can be caused by various factors, with viral infections being a significant cause. Viral liver diseases are primarily caused by hepatitis viruses, including Hepatitis A, B, C, D, and E.
Hepatitis A (HAV): HAV spreads through contaminated food or water and is usually a short-term infection. While it can cause discomfort and flu-like symptoms, it rarely leads to chronic liver disease.
Hepatitis B (HBV): HBV is transmitted through infected blood, sexual contact, or from mother to child during childbirth. Some acute HBV infections resolve on their own, but chronic infections can lead to liver cirrhosis and liver cancer.
Hepatitis C (HCV): HCV is mainly spread through blood-to-blood contact, such as sharing needles or receiving contaminated blood transfusions. It often leads to chronic infection, which, if left untreated, can cause severe liver damage.
Hepatitis D (HDV): HDV is a rare but severe form of hepatitis that occurs only in individuals infected with HBV. It worsens the course of HBV infection, leading to more severe liver disease.
Hepatitis E (HEV): HEV is usually transmitted through contaminated water and is most common in developing countries. It often resolves on its own but can be severe in pregnant women.
Prevention and management of viral liver diseases include vaccinations for Hepatitis A and B, practicing safe sex and avoiding risky behaviors, screening blood donations, and early diagnosis and treatment of chronic infections to prevent complications. Regular monitoring and adherence to medical advice are crucial for individuals with chronic viral liver diseases to improve their long-term prognosis.
Related Conference of Hepatitis and Viral Liver Diseases
7th International Conference on Gastroenterology and Liver Diseases
24th International Conference on Gastroenterology and Digestive Disorders
26th International Conference on Gastroenterology and Hepatology
20th World Congress on Gastroenterology -Therapeutics & Hepatology
17th International Conference on Liver Diseases & Hepatology
Hepatitis and Viral Liver Diseases Conference Speakers
Recommended Sessions
- Advancements in Diagnostic Imaging for GI Diseases
- Advancements in Gastrointestinal Endoscopy
- Advances in Hepatobiliary Imaging
- Artificial Intelligence (AI) and Big Data in Gastroenterology
- Emerging Therapies for Inflammatory Bowel Disease (IBD)
- Emerging Therapies in Hepatology
- Endoscopic Ultrasound (EUS) in Gastroenterology
- Functional Gastrointestinal Disorders
- Gastrointestinal Immunology and Autoimmune Diseases
- Gastrointestinal Oncology
- Gut Microbiome and Metabolic Disorders
- Hepatitis and Viral Liver Diseases
- Inflammatory Bowel Disease (IBD) and Pregnancy
- Interventional Radiology in Gastroenterology
- Liver Cirrhosis and Complications
- Liver Fibrosis and Cirrhosis Regression
- Liver Regeneration and Stem Cell Therapy
- Microbiome and Gut Health
- Nutrition in Gastrointestinal Disorders
- Pancreatic Disorders and Diabetes
- Pediatric Gastroenterology
- Therapeutic Approaches in Gastrointestinal Bleeding
- Updates in Gastrointestinal Motility Disorders
- Updates in Gastrointestinal Surgery
- Updates in Liver Transplantation
Related Journals
Are you interested in
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Gastrointestinal Therapeutics - Gastroenterology – 2025 (France)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease and Gluten-Related Disorders - Gastroenterology – 2025 (France)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Colorectal Cancer: Prevention, Screening, and Treatment - Gastroenterology – 2025 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Endoscopic Innovations and Techniques - Gastroenterology – 2025 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Functional GI Disorders: IBS and Beyond - Gastroenterology – 2025 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Antimicrobial Resistance - Gastroenterology – 2025 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology: From Screening to Targeted Therapies - Gastroenterology – 2025 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- GI Oncology: Colorectal and Pancreatic Cancers - Gastroenterology – 2025 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease (IBD): Crohn’s and Ulcerative Colitis - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease (IBD): Insights and Advancements - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Cirrhosis and Complications - Gastroenterology – 2025 (France)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastroenterology – 2025 (France)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Microbiome and Gut Health - Gastroenterology – 2025 (France)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH - Gastroenterology – 2025 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology: Challenges and Innovations - Gastroenterology – 2025 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer Disease and H. pylori Infection - Gastroenterology – 2025 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)